A Pilot Study of Extended Adjuvant Therapy with Metronomic Docetaxel for Patients with Operable Triple-Negative Breast Cancer (Q90654910)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 March 2020

edit

Language	Label	Description	Also known as
English	A Pilot Study of Extended Adjuvant Therapy with Metronomic Docetaxel for Patients with Operable Triple-Negative Breast Cancer	scientific article published on 01 March 2020

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

32212803

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32212803%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 April 2020

title

A Pilot Study of Extended Adjuvant Therapy with Metronomic Docetaxel for Patients with Operable Triple-Negative Breast Cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

32212803

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32212803%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 April 2020

main subject

triple-negative breast cancer

1 reference

based on heuristic

inferred from title

docetaxel

1 reference

based on heuristic

inferred from title

author name string

Bader A Abdelmaksoud

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

32212803

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32212803%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 April 2020

Abdelmotaleb Mohammed

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

32212803

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32212803%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 April 2020

Mostafa M Toam

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

32212803

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32212803%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 April 2020

publication date

1 March 2020

1 reference

stated in

Europe PubMed Central

PubMed publication ID

32212803

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32212803%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 April 2020

published in

Asian Pacific Journal of Cancer Prevention

1 reference

stated in

Europe PubMed Central

PubMed publication ID

32212803

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32212803%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 April 2020

volume

21

1 reference

stated in

Europe PubMed Central

PubMed publication ID

32212803

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32212803%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 April 2020

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

32212803

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32212803%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 April 2020

page(s)

749-754

1 reference

stated in

Europe PubMed Central

PubMed publication ID

32212803

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32212803%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 April 2020

cites work

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anti-angiogenic basis of metronomic chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase ii trial of a metronomic schedule of docetaxel and capecitabine with concurrent celecoxib in patients with prior anthracycline exposure for metastatic breast cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil– epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to ne

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metronomics: towards personalized chemotherapy?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary results of capecitabine metronomic chemotherapy in operable triple-negative breast cancer after standard adjuvant therapy--a single-arm phase II study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metronomic methotrexate and cyclophosphamide after carboplatin included adjuvant chemotherapy in triple negative breast cancer: a phase III study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metronomic Chemotherapy for Metastatic Breast Cancer – a Systematic Review of the Literature

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of a metronomic chemotherapy regimen with weekly low-dose docetaxel for previously treated non-small cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended Adjuvant Chemotherapy in Triple-Negative Breast Cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular Subtypes and Local-Regional Control of Breast Cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metronomic chemotherapy for non-metastatic triple negative breast cancer: Selection is the key.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triple-negative breast cancer: recent treatment advances

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/32212803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.31557/APJCP.2020.21.3.749

1 reference

stated in

Europe PubMed Central

PubMed publication ID

32212803

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32212803%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 April 2020

PMC publication ID

7437317

0 references

PubMed publication ID

32212803

1 reference

stated in

Europe PubMed Central

PubMed publication ID

32212803

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32212803%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 April 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q90654910&oldid=1577712426"